HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hirokazu Matsushita Selected Research

Necrosis

1/2020Different immunological effects of the molecular targeted agents sunitinib, everolimus and temsirolimus in patients with renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hirokazu Matsushita Research Topics

Disease

52Neoplasms (Cancer)
11/2023 - 01/2004
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2023 - 03/2011
7Lung Neoplasms (Lung Cancer)
01/2023 - 03/2016
5Testicular Neoplasms (Testicular Cancer)
01/2023 - 01/2014
4Melanoma (Melanoma, Malignant)
05/2023 - 01/2013
4Ascites
04/2022 - 04/2014
4Carcinoma (Carcinomatosis)
10/2020 - 04/2016
4Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 01/2014
4Experimental Melanoma
01/2018 - 04/2014
3Adenocarcinoma
11/2022 - 01/2017
3Stomach Neoplasms (Stomach Cancer)
01/2020 - 04/2014
2Glioblastoma (Glioblastoma Multiforme)
04/2024 - 01/2019
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2017
2Neoplasm Metastasis (Metastasis)
11/2021 - 04/2016
2Glioma (Gliomas)
01/2019 - 11/2005
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 01/2017
2Ovarian Neoplasms (Ovarian Cancer)
11/2008 - 01/2004
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2023
1Disease Progression
11/2022
1Hypoxia (Hypoxemia)
11/2022
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Esophageal Neoplasms (Esophageal Cancer)
01/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021
1Necrosis
01/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020
1Oligodendroglioma
01/2019
1Astrocytoma (Pilocytic Astrocytoma)
01/2019
1Ovarian Epithelial Carcinoma
05/2018
1Infections
01/2016

Drug/Important Bio-Agent (IBA)

16AntigensIBA
05/2023 - 11/2008
15RNA (Ribonucleic Acid)IBA
04/2024 - 01/2016
8Biomarkers (Surrogate Marker)IBA
05/2023 - 06/2014
8Immune Checkpoint InhibitorsIBA
01/2022 - 01/2017
6CytokinesIBA
12/2023 - 02/2014
5Messenger RNA (mRNA)IBA
02/2017 - 01/2004
4InterferonsIBA
05/2023 - 07/2012
4Proteins (Proteins, Gene)FDA Link
01/2017 - 11/2005
3ChemokinesIBA
12/2023 - 01/2018
3Cytostatic AgentsIBA
05/2023 - 01/2015
3Zoledronic Acid (Zometa)FDA Link
01/2020 - 03/2011
3AntibodiesIBA
12/2019 - 10/2015
3VaccinesIBA
01/2018 - 02/2014
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2016 - 03/2011
3Indicators and Reagents (Reagents)IBA
03/2015 - 01/2014
2DNA (Deoxyribonucleic Acid)IBA
12/2021 - 09/2019
2xylometazoline (stas)IBA
11/2021 - 01/2019
2Sunitinib (Sutent)FDA Link
01/2020 - 01/2014
2ImmunosorbentsIBA
12/2019 - 11/2005
2EnzymesIBA
12/2019 - 11/2005
2Neoplasm Antigens (Tumor Antigens)IBA
09/2019 - 04/2014
2Complementary DNA (cDNA)IBA
02/2017 - 11/2005
2Tyrosine Kinase InhibitorsIBA
11/2014 - 01/2014
1Transcription Factors (Transcription Factor)IBA
04/2024
1Amino AcidsFDA Link
11/2022
1Fatty Acids (Saturated Fatty Acids)IBA
11/2022
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2022
1ErbB Receptors (EGF Receptor)IBA
01/2022
1Carcinoembryonic AntigenIBA
12/2021
1PlatinumIBA
01/2021
1taxaneIBA
01/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2021
1Metformin (Glucophage)FDA LinkGeneric
01/2021
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2021
1NF-E2-Related Factor 2IBA
01/2021
1Fluorouracil (Carac)FDA LinkGeneric
01/2021
1LigandsIBA
01/2020
1Immunologic Factors (Immunomodulators)IBA
01/2020
1Complement System Proteins (Complement)IBA
01/2020
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2020
1NucleophosminIBA
01/2020
1EverolimusFDA Link
01/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2020
1pembrolizumabIBA
01/2020
1temsirolimusFDA Link
01/2020
1N-acetyltalosaminuronic acid (NAT)IBA
01/2020
1Programmed Cell Death 1 ReceptorIBA
01/2020
1B7-H1 AntigenIBA
12/2019
1HLA-DR Antigens (HLA-DR)IBA
05/2018
1Type 4 Fibroblast Growth Factor ReceptorIBA
05/2018
1Immune Checkpoint ProteinsIBA
05/2018
1MucinsIBA
05/2018
1Immunoglobulins (Immunoglobulin)IBA
05/2018
1Protein Subunit VaccinesIBA
01/2018
1GemcitabineFDA Link
01/2017
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2017
1HLA-A Antigens (HLA-A)IBA
01/2017
1EpitopesIBA
10/2015
1AutoantibodiesIBA
10/2015
1Cysteine (L-Cysteine)FDA Link
10/2015

Therapy/Procedure

22Immunotherapy
11/2023 - 09/2011
21Therapeutics
12/2023 - 06/2011
5Drug Therapy (Chemotherapy)
11/2023 - 04/2014
2Intravenous Injections
01/2017 - 08/2015
2Intraperitoneal Injections
01/2017 - 04/2014
2Nephroureterectomy
04/2016 - 06/2014
1Radiotherapy
11/2023
1Lymph Node Excision (Lymph Node Dissection)
12/2021
1Transplantation
05/2018